LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS

Podobne zapisy

• No glycemic benefit from guar administration in NIDDM.
  od: Holman, R, i wsp.
  Wydane: (1987)
• TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
  od: Holman, R, i wsp.
  Wydane: (1987)
• HUMAN ULTRALENTE INSULIN
  od: Holman, R, i wsp.
  Wydane: (1983)
• LACK OF BENEFIT FROM ACUTE ELEVATION OF PLASMA GLIBENCLAMIDE LEVELS BEFORE MEALS
  od: Turner, R, i wsp.
  Wydane: (1984)
• Human ultralente insulin.
  od: Holman, R, i wsp.
  Wydane: (1984)